PerpEquities

POET Technologies Inc. (POET) financials

NASDAQ · Technology · Semiconductors · 80 employees · CEO Suresh Venkatesan

Price
$5.20 -8.13%
Market cap
$686M
Enterprise value
$262M
Last report
Q2 '26 filed 2026-08-13
Next report
2026-11-16
Revenue (TTM)$1.71M+266.1% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)-3,340.8%+4,455.3 pp vs a year agoOperating income -$57.2M
Net income (TTM)-$75.7M-40.4% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)-$40.4M-4.8% vs a year agoCapex $5.04M
Diluted EPS (TTM)-$0.71+4.7% vs a year agoSum of the last 4 quarters
Net cash$789M+1,099.7% vs a year agoCash + short-term investments - debt

Valuation & key figures

Market cap
$686M
EV $262M
Revenue
$1.71M
Trailing 12 months
Revenue growth
+490%
FY2026 consensus
Profit margin
-4,420.7%
Net income / revenue, TTM
P/E
-7.3×
Forward -20.8× (FY2026)
P/S
400.8×
Price / sales, TTM
EV / EBITDA
-3.2×
TTM
Free cash flow
-$40.4M
Trailing 12 months
Net income
-$75.7M
Trailing 12 months
Revenue estimate
$6.35M
FY2026 consensus
Earnings
2026-11-16
Dividend
–
No dividend

Key takeaways

Computed from the reported numbers - every statement carries the figure it rests on.

  • Last report (2026-08-13): revenue beat by 14.0%, EPS in lineRevenue $570K vs $500K expected (+14.0%); EPS -$0.07 vs -$0.07 (0.0%).
  • Revenue growth slowing: 112.3% year on yearQ2 '26 revenue $570K, against an average of 3,091.9% over the four quarters before.
  • Operating margin -3,340.8% (TTM), +4,455.3 pp on a year agoOperating income grew -56.9% while revenue grew 266.1%.
  • Capex 294.5% of revenue (a year ago 1,634.2%)$5.04M invested in the last 4 quarters (-34.0% on a year earlier). Free cash flow -$40.4M.
  • Diluted share count up 100.3% in a year162M diluted shares in Q2 '26, 81.1M a year earlier.
  • Net cash $789MCash + short-term investments $796M, debt incl. leases $7.8M; a year ago net cash $65.7M.

Last quarter: Q2 '26

Quarter ended 2026-06-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.

Quarter vs a year ago

Q2 '26Year agoChange
Revenue$570K$268K+112.3%
Gross margin-80.2%100.0%-180.2 pp
Operating income-$20.2M-$8.76M-130.6%
Operating margin-3,542.7%-3,261.9%-280.8 pp
Net income-$11.3M-$17.3M+34.3%
Diluted EPS-$0.07-$0.21+66.8%
Operating cash flow-$12.2M-$7.74M-57.3%
Capex$2.98M$2.11M+41.3%
Free cash flow-$15.2M-$9.85M-53.9%
R&D$6.99M$3.75M+86.4%
Stock-based compensation$0$1.17M-100.0%

Reported vs consensus

2026-08-13
ActualConsensusvs consensus
Revenue$570K$500K+14.0%
EPS (as estimated)-$0.07-$0.070.0%

From the report of 2026-08-13 for Q2 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.

EPS vs consensus

last 8 reports

Revenue

Where the money comes from - by business line and by region, quarter by quarter.

Revenue, operating income and growth

quarterly

Margins & cost structure

How much of each unit of revenue is left at each level - and where the costs go.

Margins

quarterly

Costs as % of revenue

quarterly

Cash flow & capital allocation

Cash generated, what it is spent on, and what reaches shareholders.

Operating cash flow, capex, free cash flow

quarterly

Uses of cash vs operating cash flow

fiscal years

Last 4 quarters

cash flow statement
Operating cash flow
-$35.3M
Capex
-$5.04M
Buybacks
$0
Dividends
$0
Acquisitions
$0
Net debt issued
-$1.03M
Stock-based compensation
$2.24M
Free cash flow
-$40.4M
Returned to shareholders / FCF
0.0%

Share count and EPS

quarterly, diluted

Balance sheet

Liquidity, investments and debt at each quarter end.

Cash, investments and debt

quarter ends

Valuation & returns

Today's multiples against the company's own last five fiscal years; analyst targets and ratings.

Multiples and returns

TTM vs 5 fiscal years
Now5y averageWhere today sits in the 5-year range
P/E (TTM)-7.3×––
EV / EBITDA-3.2×––
EV / Sales152.8×1,962.5×75.2× – 7,931.3×
Price / FCF-17.0×––
Price / Book1.0×9.5×3.2× – 17.3×
FCF yield-5.9%-15.5%-44.4% – -5.0%
Return on invested capital-6.7%-145.5%-372.8% – -17.7%
Return on equity-19.6%-193.2%-411.0% – -34.3%

Analysts

Consensus target $5.75 (+10.6%)
range $3.50 – $8.00 · rating Buy

Strong buy0
Buy2
Hold0
Sell0
Strong sell0

Outlook

Analyst consensus for the coming fiscal years and what it implies at today's price.

Consensus estimates

Fiscal yearRevenueGrowthEPSGrowthP/E at today's priceAnalysts (EPS)
FY2026$6.35M+490.5%-$0.25+63.2%-20.8×1
FY2027$82M+1,192.0%-$0.18+30.0%-29.7×1
FY2028$200M+143.9%$0.02+111.4%260.0×1
FY2029$405M+102.5%$0.42+2,000.0%12.4×1
FY2030$600M+48.1%$0.68+61.9%7.6×1

Financial statements

Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings.

Data as of 2026-11-02